Andrea Richter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Andrea Richter has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Andrée Rasquin
Services de génétique médicale et de gastroentérologie, Hôpital Sainte Justine, Département de pédiatrie, Université de Montréal, 3175, chemin de la Côte Sainte-Catherine, Montréal (Québec) H3T 1C5, Canada
1 shared publicationAndrée Rasquin-Weber
Divisions of 1Medical Genetics and 2Gastroenterology, Hôpital Ste-Justine, Centre Hospitalier Universitaire Mère-Enfant, Université de Montréal, and 3Montréal Genome Centre, McGill University Health Centre Research Institute, Montréal
1 shared publicationAnne-Marie Houle
Division of Urology, Hôpital Sainte-Justine, Centre Hospitalier Universitaire Mère-Enfant, Departments of Pediatrics and Surgery, Université de Montréal, Montreal, Quebec, Canada
1 shared publication- Arnulf H. Koeppen
VA Medical Center
1 shared publication Eric Drouin
Divisions of 1Medical Genetics and 2Gastroenterology, Hôpital Ste-Justine, Centre Hospitalier Universitaire Mère-Enfant, Université de Montréal, and 3Montréal Genome Centre, McGill University Health Centre Research Institute, Montréal
1 shared publication- Grant A. Mitchell
Division of Medical Genetics and Genomics, Department of Pediatrics, CHU Sainte-Justine and Université de Montréal, Montreal, Canada
1 shared publication
Latest Publications
- 13 February 2008
- Published by Hindawi Limited in Human Mutation
- Vol. 29 (5) , 695-702
RET Gly691Ser mutation is associated with primary vesicoureteral reflux in the French-Canadian population from Quebec
Primary vesicoureteral reflux (pVUR) is a common, genetically heterogeneous congenital urinary tract abnormality in children. It causes urine to flow backward from the bladder to the ureter due to a developmental defect at the vesicoureteral junction, whose formation requires rearrangement during transformation (Ret)-mediated signaling pathways. To study the genetic causes of pVUR in Quebec patients, we used a sequencing-based candidate gene approach to screen the RET gene and found that 83 out of 118 pVUR patients are carriers of the rare A allele of single nucleotide polymorphism (SNP) rs1799939:G>A that results in a Gly691Ser mutation, a statistically significant increase in allelic frequency, that is absent at six flanking RET SNPs tested. Ser691 is a predicted phosphorylation site and our analysis of transfected cells showed that the Gly691Ser Ret mutant can efficiently interact and associate with a 75–80-kD tyrosine phosphorylated cellular protein, an event not seen with wild-type Ret. This interaction and/or the steric or electric hindrance created by phospho-Ser691 may interfere with the known regulatory functions of the normally phosphorylated phospho-Tyr687 and phospho-Ser696 on the cytoskeleton actin reorganization that are responsible for cell motility and morphology, which consequently may lead to the deficiency in ureteral development observed in pVUR. Our study demonstrates that the Ret Gly691Ser mutation is associated with pVUR and may be one of the genetic causes of this condition in the French-Canadian population in Quebec. Hum Mutat 29(5), 695–702, 2008.
- 13 February 2008
- Published by Hindawi Limited in Human Mutation
- Vol. 29 (5) , 695-702
RET Gly691Ser mutation is associated with primary vesicoureteral reflux in the French-Canadian population from Quebec
Primary vesicoureteral reflux (pVUR) is a common, genetically heterogeneous congenital urinary tract abnormality in children. It causes urine to flow backward from the bladder to the ureter due to a developmental defect at the vesicoureteral junction, whose formation requires rearrangement during transformation (Ret)-mediated signaling pathways. To study the genetic causes of pVUR in Quebec patients, we used a sequencing-based candidate gene approach to screen the RET gene and found that 83 out of 118 pVUR patients are carriers of the rare A allele of single nucleotide polymorphism (SNP) rs1799939:G>A that results in a Gly691Ser mutation, a statistically significant increase in allelic frequency, that is absent at six flanking RET SNPs tested. Ser691 is a predicted phosphorylation site and our analysis of transfected cells showed that the Gly691Ser Ret mutant can efficiently interact and associate with a 75–80-kD tyrosine phosphorylated cellular protein, an event not seen with wild-type Ret. This interaction and/or the steric or electric hindrance created by phospho-Ser691 may interfere with the known regulatory functions of the normally phosphorylated phospho-Tyr687 and phospho-Ser696 on the cytoskeleton actin reorganization that are responsible for cell motility and morphology, which consequently may lead to the deficiency in ureteral development observed in pVUR. Our study demonstrates that the Ret Gly691Ser mutation is associated with pVUR and may be one of the genetic causes of this condition in the French-Canadian population in Quebec. Hum Mutat 29(5), 695–702, 2008.
- Open Access
- 15 November 2007
- Published by EDP Sciences in médecine/sciences
- Vol. 23 (11) , 1002-1007
La cirrhose amérindienne infantile
Nous décrivons ici comment une maladie survenant uniquement chez les enfants amérindiens du Nord-Ouest du Québec a pu être diagnostiquée et le gène responsable détecté. Il s’agit d’une cholestase néonatale évoluant irrémédiablement vers la cirrhose et pour laquelle la transplantation hépatique représente actuellement la seule solution thérapeutique. La maladie est transmise de façon autosomique récessive et le taux des porteurs du gène muté est de 10 % dans les communautés concernées. Dans tous les cas détectés à ce jour, la mutation provoque la substitution d’un acide aminé (R565W) dans la protéine cirhin, produit du locus CIRH1A. North American Indian childhood cirrhosis is a distinct form of neonatal familial cholestasis. To date, it has only been described in aboriginal children from northwestern Quebec. The disease rapidly evolves into cirrhosis with early portal hypertension and bleeding from esophageal varices. Twelve of 36 children followed at l’Hôpital Ste-Justine since 1970 received a liver transplant. As of now, there are 17 living NAIC patients, 6 of whom had liver transplantation. We mapped NAIC to chromosome 16q22, and identified mutations in CIRH1A in patients. All are homozygous for the R565W mutation in cirhin, a WD40 repeat protein of unknown function. We showed that cirhin is a resident in the nucleolus. Cirhin interacts with Cirip, a functional, alternative splice variant of the HIVEP1 protein. Their interaction indicates synergistic action. The complete inactivation of mouse homolog, tex292 is likely embryonic lethal. The continued collaboration between patients, their families, clinicians and researchers that has helped to identify the disease gene and to develop a diagnostic test now focuses on finding a new treatment for this unique disease affecting First Nations children from Québec.
- 15 November 2007
- Published by EDP Sciences in médecine/sciences
- Vol. 23 (11) , 1002-1007
Open AccessLa cirrhose amérindienne infantile
Nous décrivons ici comment une maladie survenant uniquement chez les enfants amérindiens du Nord-Ouest du Québec a pu être diagnostiquée et le gène responsable détecté. Il s’agit d’une cholestase néonatale évoluant irrémédiablement vers la cirrhose et pour laquelle la transplantation hépatique représente actuellement la seule solution thérapeutique. La maladie est transmise de façon autosomique récessive et le taux des porteurs du gène muté est de 10 % dans les communautés concernées. Dans tous les cas détectés à ce jour, la mutation provoque la substitution d’un acide aminé (R565W) dans la protéine cirhin, produit du locus CIRH1A. North American Indian childhood cirrhosis is a distinct form of neonatal familial cholestasis. To date, it has only been described in aboriginal children from northwestern Quebec. The disease rapidly evolves into cirrhosis with early portal hypertension and bleeding from esophageal varices. Twelve of 36 children followed at l’Hôpital Ste-Justine since 1970 received a liver transplant. As of now, there are 17 living NAIC patients, 6 of whom had liver transplantation. We mapped NAIC to chromosome 16q22, and identified mutations in CIRH1A in patients. All are homozygous for the R565W mutation in cirhin, a WD40 repeat protein of unknown function. We showed that cirhin is a resident in the nucleolus. Cirhin interacts with Cirip, a functional, alternative splice variant of the HIVEP1 protein. Their interaction indicates synergistic action. The complete inactivation of mouse homolog, tex292 is likely embryonic lethal. The continued collaboration between patients, their families, clinicians and researchers that has helped to identify the disease gene and to develop a diagnostic test now focuses on finding a new treatment for this unique disease affecting First Nations children from Québec.
- 20 May 2004
- Published by Springer Nature in neurogenetics
- Vol. 5 (3) , 165-170
Private SACS mutations in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) families from Turkey
We studied five families with pediatric-onset recessive spastic ataxia from Turkey. The clinical characteristics and linkage studies are compatible with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). SACS mutations are responsible for ARSACS in Québec families. In four of the five families tested we detected new disease-causing mutations using automated sequencing of SACS. Our study raises to 12 the number of SACS mutations detected in ARSACS patients with origins around the Mediterranean basin.
- 20 May 2004
- Published by Springer Nature in neurogenetics
- Vol. 5 (3) , 165-170
Private SACS mutations in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) families from Turkey
We studied five families with pediatric-onset recessive spastic ataxia from Turkey. The clinical characteristics and linkage studies are compatible with autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS). SACS mutations are responsible for ARSACS in Québec families. In four of the five families tested we detected new disease-causing mutations using automated sequencing of SACS. Our study raises to 12 the number of SACS mutations detected in ARSACS patients with origins around the Mediterranean basin.
- 1 December 2002
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 71 (6) , 1443-1449
A Missense Mutation (R565W) in Cirhin (FLJ14728) in North American Indian Childhood Cirrhosis
- 1 December 2002
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 71 (6) , 1443-1449
A Missense Mutation (R565W) in Cirhin (FLJ14728) in North American Indian Childhood Cirrhosis
- 1 April 2002
- Published by Springer Nature in The Cerebellum
- Vol. 1 (2) , 143-158
A symposium of the Society for Experimental Neuropathology under the auspices of the American Neurological Association
- 1 April 2002
- Published by Springer Nature in The Cerebellum
- Vol. 1 (2) , 143-158
A symposium of the Society for Experimental Neuropathology under the auspices of the American Neurological Association